Zentalis Pharmaceuticals shares owned by Paradigm Biocapital Advisors
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Paradigm Biocapital Advisors
from 13F filings
Historical chart of Paradigm Biocapital Advisors investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Zentalis Pharmaceuticals by Paradigm Biocapital Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $6.1M | 400k | 15.15 |
2022-03-31 | $13M | 288k | 46.14 |
2021-12-31 | $25M | 300k | 84.06 |
More positions owned by Paradigm Biocapital Advisors
View all positions for Paradigm Biocapital Advisors